PURPOSE: Laparoscopic ventral hernia repair with mesh versus laparoscopic ventral hernia defect closure with mesh reinforcement. The primary end-point was recurrence. METHODS: Retrospective review of patients who underwent laparoscopic ventral hernia repair for small- and medium-sized hernias between July 2000 and September 2011. These patients were divided: (1) repair with mesh alone (non-closure group) and (2) those with hernia defect closure and mesh reinforcement (closure group). The closure group was further divided by technique: percutaneous versus intracorporeal closure of the defect. RESULTS: 128 patients were studied: 93 patients (72.66 %) in the non-closure group and 35 patients (27.34 %) in the closure group. Follow-up was available in 105 patients (82.03 %) at a mean of 797.2 days (range 7-3,286 days). In the non-closure group there were 14 patients (15.05 %) with postoperative complications and 8 patients (22.86 %) in the closure group, four of which were seromas. Fourteen patients (19.18 %) developed recurrent hernias in the non-closure group with an average time to presentation of 23.17 months (range 5.3-75.3). Two patients (6.25 %) developed recurrent hernias in the percutaneous group with an average time to presentation of 12.95 months (range 9.57-16.33). There have been no recurrences in patients whose defect was closed intracorporeally. CONCLUSION: Although our study demonstrated a difference in recurrence rates of 19.18 % in the non-closure group versus 6.25 % in the closure group, the difference did not reach statistical significance. A larger series with longer follow-up may demonstrate clinical significance.
PURPOSE: Laparoscopic ventral hernia repair with mesh versus laparoscopic ventral hernia defect closure with mesh reinforcement. The primary end-point was recurrence. METHODS: Retrospective review of patients who underwent laparoscopic ventral hernia repair for small- and medium-sized hernias between July 2000 and September 2011. These patients were divided: (1) repair with mesh alone (non-closure group) and (2) those with hernia defect closure and mesh reinforcement (closure group). The closure group was further divided by technique: percutaneous versus intracorporeal closure of the defect. RESULTS: 128 patients were studied: 93 patients (72.66 %) in the non-closure group and 35 patients (27.34 %) in the closure group. Follow-up was available in 105 patients (82.03 %) at a mean of 797.2 days (range 7-3,286 days). In the non-closure group there were 14 patients (15.05 %) with postoperative complications and 8 patients (22.86 %) in the closure group, four of which were seromas. Fourteen patients (19.18 %) developed recurrent hernias in the non-closure group with an average time to presentation of 23.17 months (range 5.3-75.3). Two patients (6.25 %) developed recurrent hernias in the percutaneous group with an average time to presentation of 12.95 months (range 9.57-16.33). There have been no recurrences in patients whose defect was closed intracorporeally. CONCLUSION: Although our study demonstrated a difference in recurrence rates of 19.18 % in the non-closure group versus 6.25 % in the closure group, the difference did not reach statistical significance. A larger series with longer follow-up may demonstrate clinical significance.
Authors: John A Girotto; Michael Chiaramonte; Nathan G Menon; Navin Singh; Ron Silverman; Anthony P Tufaro; Maurice Nahabedian; Nelson H Goldberg; Paul N Manson Journal: Plast Reconstr Surg Date: 2003-07 Impact factor: 4.730
Authors: Jacobus W A Burger; Roland W Luijendijk; Wim C J Hop; Jens A Halm; Emiel G G Verdaasdonk; Johannes Jeekel Journal: Ann Surg Date: 2004-10 Impact factor: 12.969
Authors: Richard A Pierce; Jennifer A Spitler; Margaret M Frisella; Brent D Matthews; L Michael Brunt Journal: Surg Endosc Date: 2006-12-16 Impact factor: 3.453
Authors: Omar Rodriguez-Acevedo; Kristen E Elstner; Anita S W Jacombs; John W Read; Rodrigo Tomazini Martins; Fernando Arduini; Michael Wehrhahm; Colette Craft; Peter H Cosman; Anthony N Dardano; Nabeel Ibrahim Journal: Surg Endosc Date: 2017-07-21 Impact factor: 4.584
Authors: David Nguyen; Samuel Szomstein; Alex Ordonez; Fernando Dip; Meenakshi Rajan; Emanuele Lo Menzo; Raul J Rosenthal Journal: Surg Endosc Date: 2015-06-24 Impact factor: 4.584
Authors: Nestor A Arita; Mylan T Nguyen; Duyen H Nguyen; Rachel L Berger; Debbie F Lew; James T Suliburk; Erik P Askenasy; Lillian S Kao; Mike K Liang Journal: Surg Endosc Date: 2014-10-08 Impact factor: 4.584
Authors: Christina M Papageorge; Luke M Funk; Benjamin K Poulose; Sharon Phillips; Michael J Rosen; Jacob A Greenberg Journal: Surg Endosc Date: 2017-04-04 Impact factor: 4.584
Authors: John Emil Wennergren; Erik P Askenasy; Jacob A Greenberg; Julie Holihan; Jerrod Keith; Mike K Liang; Robert G Martindale; Skylar Trott; Margaret Plymale; John Scott Roth Journal: Surg Endosc Date: 2015-11-17 Impact factor: 4.584